Corticosteroid-Responsive Dermatoses Market: By Type (Glucocorticoids and Mineralocorticoids), By Disorder (Rheumatoid Neutrophilic Dermatoses, Acute febrile Neutrophilic Dermatoses, Others) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0224

Updated Date: 31 May, 2018  

1. Corticosteroid-Responsive Dermatoses Market – Market Overview
2. Executive Summary
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Corticosteroid-Responsive Dermatoses Market– Market Forces
   4.1. Drivers
      4.1.1. Development of new technology
      4.1.2. Rise in the demand for corticosteroid-responsive dermatoses
      4.1.3. Increasing government initiative
   4.2. Restraints
      4.2.1. Higher cost of research and development
      4.2.2. Harmful side effects
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Increase in adoption of corticosteroid-responsive dermatoses
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Corticosteroid-Responsive Dermatoses Market, By Disorder
   5.1. Rheumatoid Neutrophilic Dermatoses
   5.2. Acute febrile Neutrophilic Dermatoses
   5.3. Dermatoses Papulosa Nigra
   5.4. Dermatoses Neglecta
   5.5. Dermatoses Cinecienta
   5.6. Linear Lichenoid Dermatoses
   5.7. Digitate Dermatoses
   5.8. Contagious Pustular Dermatoses
   5.9. Transient Acantholytic Dermatoses
   5.10. Juvenile plantar Dermatoses
6. Corticosteroid-Responsive Dermatoses Market, By Type
   6.1. Glucocorticoids
   6.2. Mineralocorticoids
7. Corticosteroid-Responsive Dermatoses Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Corticosteroid-Responsive Dermatoses – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. Novartis International AG
   9.2. GlaxoSmithKline plc
   9.3. Pfizer Inc.
   9.4. Medcis
   9.5. Nycomed US Inc
   9.6. Merck
   9.7. Nova Biomedical Corporation
   9.8. Pharmaco-Kinesis Corporation
   9.9. Incyte Corporation
   9.10. Bayer AG
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights